U.S. Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108778

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 9.9% from 2024 to 2032
Unit	Value (USD Billion)
Segmentation	By Drug Class Buprenorphine Methadone Naltrexone
	By Route of Administration Oral Parenteral
	By Distribution Channel Hospital Pharmacies Retail Pharmacies & Stores Online Pharmacies